98%
921
2 minutes
20
Background: Little is documented on key community-based One Health (OH) approach implementation, pro-activeness and effectiveness of interactions and strategies against Mpox outbreak public health emergency in international concern (PHEIC) in various African countries in order to stamp out the persisting Mpox outbreak threat and burden. Prioritizing critical community-based interventions and lessons learned from previous COVID-19, Mpox, Ebola, COVID-19, Rift Valley Fever and Marburg virus outbreaks revealed critical shortcomings in funding, surveillance, and community engagement that plague public health initiatives across the continent. The article provides critical insights and benefits of community-based One Health approaches implementation against Mpox outbreak management in Africa.
Main Body: Our findings provides a comprehensive community and primary healthcare systems strategies essential to foster community engagement and resilience, while addressing the social determinants of health. Investing in targeted, effective and contextual community-based OH strategies implementation shows to improve immediate vulnerable communities integrated (human,animal and environment) preparedness and response and building sustainable resilience strategies against Mpox and future emergencies threats. The importance of global and regional multi-sectorial collaboration, solidarity and coordination cannot be over-emphasized, to mobilize resource, sharing knowledge and successes in enhancing local OH anticipatory and ownership programs capabilities for equitably shared benefits. Timely strengthening community empowerment and national health systems last miles, WASH and vaccination activities are essential to control, contain and sustainable recovery from the ongoing Mpox outbreak and future crises. Tackling survivors and at high risk affected populations stigma, fear and misinformation surrounding Mpox those hinder effective health communication and disease management, highlighting the need for culturally sensitive educational and empowerment strategies. A comprehensive assessment community-based one-health approaches implementation was performed to understand and prioritize key data-driven community-based OH strategies in infectious disease outbreaks beyond. Leveraging on outbreak valuable lessons learned and emerging technologies benefits in addressing the health social determinants, optimizing Mpox PHEIC implemented programs capabilities efforts, building communities resilience and sustainable solutions, and prioritizing strategies against outbreaks/pandemics threats and burden.
Conclusions: Catalyzing evidence-based community-based OH governance, leadership and domestic financing commitment serve as a critical engine connecting all stakeholders in prioritizing and optimizing unprecedented outbreaks threats preparedness and response initiatives implementation and upholding global health security returns.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1186/s40249-025-01348-y | DOI Listing |
Infect Dis Poverty
September 2025
Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
Background: Little is documented on key community-based One Health (OH) approach implementation, pro-activeness and effectiveness of interactions and strategies against Mpox outbreak public health emergency in international concern (PHEIC) in various African countries in order to stamp out the persisting Mpox outbreak threat and burden. Prioritizing critical community-based interventions and lessons learned from previous COVID-19, Mpox, Ebola, COVID-19, Rift Valley Fever and Marburg virus outbreaks revealed critical shortcomings in funding, surveillance, and community engagement that plague public health initiatives across the continent. The article provides critical insights and benefits of community-based One Health approaches implementation against Mpox outbreak management in Africa.
View Article and Find Full Text PDFJ Infect Dis
September 2025
Biological Sciences, Sunnybrook Research Institute, Sunnybrook Hospital, Toronto, Ontario, Canada.
Background: Tecovirimat (TPOXX) is an antiviral authorized for the treatment of mpox infections in Canada, but recent clinical trials found it has no impact on symptom duration.
Methods: We conducted a prospective cohort study of individuals diagnosed with mpox in Toronto, Canada. Skin lesion swabs were collected weekly to quantify infectious monkeypox virus (MPXV) shedding through cell culture.
Sex Transm Dis
September 2025
Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Montefiore Health System, Bronx, NY, USA.
Background: Men who have sex with men (MSM) and transgender women (TGW) are at elevated mpox risk; vaccination can greatly reduce that risk. We assessed mpox awareness and vaccine acceptability among MSM and TGW.
Methods: In 2022, hybrid-mode (offline/online) surveys were administered among 250 MSM and 251 TGW in Chennai, India.
EMBO Mol Med
September 2025
Institute of Physical Science and Information, Anhui University, 230039, Hefei, Anhui, China.
The global outbreak of the mpox in humans, caused by the mpox virus (MPXV), underscores the urgent need for safe and effective therapeutics. In this study, we characterized the dominant MPXV immunogens, M1R and B6R, by sequencing monoclonal antibodies (MAbs) from the immunized mice and analyzing their epitopes and functions through in vitro and in vivo assessments of binding and antiviral activities. Several broadly effective anti-M1R and anti-B6R neutralizing MAbs were identified and they exhibited enhanced antiviral effects against MPXV or vaccinia virus (VACV) when used in antibody cocktail and bispecific antibody designs.
View Article and Find Full Text PDFMed Sci (Paris)
September 2025
UMI233 TransVIHMI (Recherches translationnelles sur le VIH et les maladies infectieuses), Université de Montpellier, IRD, INSERM Unité 1175, Montpellier, France.
For a long time neglected, the mpox virus has caused two public health emergency declarations by the World Health Organization in just two years. Rapid detection and characterization of the viral strains involved are crucial for better control of the disease. Recent work on viral genome sequencing in the Democratic Republic of the Congo (DRC) has shown the emergence in 2023 of clade Ib, with sustained human-to-human transmission and rapid spread to several other non-endemic neighboring countries, as well as outside Africa.
View Article and Find Full Text PDF